HHS To Form Outside Committee On Reshaping Medicare, Medicaid

The Department of Health and Human Services (HHS) will seek external experts for a new committee tasked with providing strategic guidance on the care provided by government insurance programs.

The HHS announced Thursday that the Healthcare Advisory Committee will offer recommendations to Secretary Robert F. Kennedy Jr. and Centers for Medicare & Medicaid Services (CMS) Administrator Mehmet Oz, M.D., seeking to “improve how care is financed and delivered” across Medicare, Medicaid, the Children’s Health Insurance Program and the Affordable Care Act’s exchanges.

The CMS is currently accepting nominations for committee members and is looking for experts in chronic disease management, financing in federal health programs and delivery system reform. Individuals can either be nominated by an organization or submit a nomination for themselves.

“This is a moment for action,” Oz said in an announcement. “This committee will help us cut waste, reduce paperwork, expand preventive care and modernize CMS programs with real-time data and accountability, all while keeping patients at the center.”

The announcement outlines several key focus areas for which the committee will develop recommendations. For one, it will be tasked with creating actionable policies to promote chronic disease prevention and management. In addition, it will seek to establish a regulatory framework that promotes patient safety while reducing “unnecessary red tape.”

The committee members will also work to advance a real-time data system that allows for faster claims processing and quality measurement as well as to identify “structural opportunities” to improve the Medicaid program.

Finally, the committee will examine the sustainability of Medicare Advantage, building a more modern approach to risk adjustment and quality measurement in the program, the CMS said.

The CMS said in the announcement that nominations will be accepted for 30 days after the call goes live on the Federal Register, a date set for Aug. 22, with the full list of committee members to be published later this year.

“Every American high-quality, affordable care—without red tape, corporate greed, or excessive costs,” said RFK Jr. “This new advisory committee will unite the best minds in healthcare to help us deliver real results, hold the system accountable, and drive forward our mission to Make America Healthy Again.”

 

Source Link

Recommended Articles

Trump Administration Demands Hospitals Share Emergency Room Records

A tiny federal agency tasked with protecting the public from injuries caused by lawn mowers and coffeemakers is demanding that some of the nation’s biggest health systems turn over detailed, personally identifiable medical records of all patients who seek help at their emergency rooms. The Consumer Product Safety Commission, responsible for tracking and issuing recalls ...

Read More

21 States File Lawsuit Challenging 2027 ACA Payment Rule

A coalition of attorneys general from 21 states, along with Pennsylvania Gov. Josh Shapiro, have filed a lawsuit challenging a federal rule that they allege undermines the Affordable Care Act and makes health insurance more expensive and harder to obtain for millions of Americans. The lawsuit seeks to block provisions of the Trump administration’s ACA ...

Read More

Erica Schwartz, Trump’s CDC Pick Wins Senate Confirmation

The Senate voted to confirm President Donald Trump’s nominee, Erica Schwartz, to run the Centers for Disease Control and Prevention on Wednesday, ending a nearly yearlong period without a Senate-confirmed director leading the agency. Schwartz was confirmed in a 51-44 vote, with Sen. Tim Kaine (D-Va.) joining Republicans in support. All other Democrats opposed the nomination. Despite a ...

Read More

Specialty Drug Costs Expected To Jump 32% By 2028, PSG Finds

Specialty drug trend remains high, although it decreased from 11.2% to 10.8% on a gross cost basis in Pharmacy Strategies Group’s 2026 State of Specialty Spend and Trend Report. Claim utilization is now the dominant driver of specialty drug trend as the percentage of members using specialty drugs rose to 5.5%. “For a decade, this report ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square